Fintel on MSN6d
BMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform Recommendation
Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...
BMO Capital Markets Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)
BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, Ratings reports. The brokerage issued an outperform ...
Investing3d
Rocket Lab USA, Inc. (RKLB)
On Wednesday, Stifel analysts reiterated their Buy rating and $27.00 price target for Rocket Lab USA (NASDAQ:RKLB) shares, which ...
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $52.00 at Scotiabank
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price target lifted by stock analysts at Scotiabank from ...
CNN1y
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals ... Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based ...
Investing3d
Rocket Lab USA, Inc. (RKLB)
On Thursday, BofA Securities increased its price target for Rocket Lab USA (NASDAQ:RKLB) shares, setting a new goal of $30, up ...